Lehto M, Tuomi T, Mahtani M M, Widén E, Forsblom C, Sarelin L, Gullström M, Isomaa B, Lehtovirta M, Hyrkkö A, Kanninen T, Orho M, Manley S, Turner R C, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen M R, Groop L
Department of Endocrinology, Wallenberg Laboratory, Malmö University Hospital, Sweden.
J Clin Invest. 1997 Feb 15;99(4):582-91. doi: 10.1172/JCI119199.
Maturity-onset diabetes of the young (MODY) type 3 is a dominantly inherited form of diabetes, which is often misdiagnosed as non-insulin-dependent diabetes mellitus (NIDDM) or insulin-dependent diabetes mellitus (IDDM). Phenotypic analysis of members from four large Finnish MODY3 kindreds (linked to chromosome 12q with a maximum lod score of 15) revealed a severe impairment in insulin secretion, which was present also in those normoglycemic family members who had inherited the MODY3 gene. In contrast to patients with NIDDM, MODY3 patients did not show any features of the insulin resistance syndrome. They could be discriminated from patients with IDDM by lack of glutamic acid decarboxylase antibodies (GAD-Ab). Taken together with our recent findings of linkage between this region on chromosome 12 and an insulin-deficient form of NIDDM (NIDDM2), the data suggest that mutations at the MODY3/NIDDM2 gene(s) result in a reduced insulin secretory response, that subsequently progresses to diabetes and underlines the importance of subphenotypic classification in studies of diabetes.
青年发病的成年型糖尿病(MODY)3型是一种常被误诊为非胰岛素依赖型糖尿病(NIDDM)或胰岛素依赖型糖尿病(IDDM)的显性遗传糖尿病。对四个大型芬兰MODY3家系(与12号染色体连锁,最大对数优势分数为15)成员的表型分析显示,胰岛素分泌严重受损,这种情况在那些继承了MODY3基因的血糖正常的家庭成员中也存在。与NIDDM患者不同,MODY3患者没有表现出胰岛素抵抗综合征的任何特征。他们可以通过缺乏谷氨酸脱羧酶抗体(GAD-Ab)与IDDM患者区分开来。结合我们最近关于12号染色体上该区域与胰岛素缺乏型NIDDM(NIDDM2)之间连锁关系的发现,这些数据表明MODY3/NIDDM2基因的突变导致胰岛素分泌反应降低,随后发展为糖尿病,并强调了亚表型分类在糖尿病研究中的重要性。